Advertisement
Tuesday, 07 February 2023
E-paper
Home
Opinion
India
My Kolkata
News
Places
People
Lifestyle
Events
Food
Try This
Edugraph
News
Career
Campus
18 Under 18
Colleges
States
West Bengal
North East
Jharkhand
World
Business
Science & Tech
Health
Sports
Cricket
Football
Horse Racing
Entertainment
Culture
Bob Dylan@80
Heritage
Travel
Style
People
Books
Food
Arts
Music
Gallery
Search
Home
/
Topic
/
Sun Pharmaceutical Industries
Sun Pharmaceutical Industries
Business
/
Published 02.11.22
Adani Ports profit up 65% at Rs 1738cr
Company’s overall revenue rises 20.7 per cent to Rs 13,129 crore in the second quarter of current fiscal...
By Our Bureau in New Delhi
Business
/
Published 31.05.22
Sun Pharma loss at Rs 2277cr
The Mumbai-based drug major had reported a net profit of Rs 894 crore in the January-March period of 2020-21...
By Our Bureau in Mumbai
Business
/
Published 31.07.21
Sun Pharma net at Rs 1444cr
The better-than-expected results saw its shares surging over 10 per cent on the bourses...
By Our Bureau in Calcutta, Mumbai
Business
/
Published 28.05.21
Sun Pharma net profit jumps two-fold
The company had posted a net profit of Rs 399.84 crore in the corresponding period of the previous fiscal, compared to the present Rs 894.15 crore...
By Our Bureau in New Delhi
Business
/
Published 12.02.21
Sun Pharma settles whistleblower suit
It was alleged that they had been diverting funds through Aditya Medisales Ltd (AML), its sole distributor in India...
By Our Special Correspondent in Mumbai
Advertisement
Business
/
Published 30.03.20
Curbs on Sun Pharma
Supplies to the US from its Halol unit contribute around 3-4 per cent of the company’s consolidated revenues...
By Our Special Correspondent in Mumbai
Business
/
Published 17.03.20
Sun Pharmaceutical buyback of Rs 1700 crore
At maximum buy-back size and price, the maximum number of equity shares to be bought back would be 4 crore...
By Our Special Correspondent in New Delhi
Business
/
Published 13.03.20
Sun Pharma to consider buyback
During intra-day trade, the stock had hit a high of Rs 402.85, a gain of 13.52 per cent ...
By Our Special Correspondent in Mumbai
Business
/
Published 22.01.19
Sun Pharma tries to limit damage
After whistleblower complaint, company replaces its domestic formulations distributor Aditya Medisales...
By Our Bureau in Mumbai
Business
/
Published 03.12.18
Sun Pharma bid to limit damage
The company's shares have come under pressure after a foreign brokerage raised concerns over its corporate governance...
By Our Special Correspondent in Mumbai
Advertisement
Download our latest App
to get update on the go...
Advertisement
Advertisement
Copyright © 2020 The Telegraph. All rights reserved.
About
|
Contact us
|
Terms of use
|
Privacy Policy